(Q38221424)

English

Mammalian target of rapamycin inhibitors are associated with lower rates of hepatocellular carcinoma recurrence after liver transplantation: a systematic review.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24943720%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Mammalian target of rapamycin inhibitors are associated with lower rates of hepatocellular carcinoma recurrence after liver transplantation: a systematic review (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24943720%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

liver transplantation

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24943720%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Evangelos Cholongitas

1

object named as

Evangelos Cholongitas

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24943720%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

author name string

Chrysanthi Mamou

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24943720%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Kryssia I Rodríguez-Castro

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24943720%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

publication date

18 July 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24943720%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Transplant International

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24943720%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

27

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24943720%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24943720%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1039-1049

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24943720%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Optimization of the use of Calcineurin inhibitors in liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

Chronic renal failure after transplantation of a nonrenal organ

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

Hypertension and renal dysfunction in long-term liver transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

Cyclosporine induces cancer progression by a cell-autonomous mechanism.

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

mTOR inhibitors: an overview

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

Meta-analysis: recurrence and survival following the use of sirolimus in liver transplantation for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

Microvascular invasion is a better predictor of tumor recurrence and overall survival following surgical resection for hepatocellular carcinoma compared to the Milan criteria

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

Immunosuppression induction with rabbit anti-thymocyte globulin with or without rituximab in 1000 liver transplant patients with long-term follow-up

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

Safety and efficacy of four steroid-minimization protocols in liver transplant recipients: 3-year follow-up in a single center

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

Reduced-dose tacrolimus with mycophenolate mofetil vs. standard-dose tacrolimus in liver transplantation: a randomized study

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

Once-daily prolonged-release tacrolimus (ADVAGRAF) versus twice-daily tacrolimus (PROGRAF) in liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

Early withdrawal of calcineurin inhibitors and everolimus monotherapy in de novo liver transplant recipients preserves renal function.

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

A randomized, controlled study to assess the conversion from calcineurin-inhibitors to everolimus after liver transplantation--PROTECT.

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

Late recurrence of hepatocellular carcinoma after liver transplantation: is an active surveillance for recurrence needed?

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

Expanded criteria for liver transplantation in patients with cirrhosis and hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

University of Modena experience in HIV-positive patients undergoing liver transplantation.

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

Sirolimus therapy in liver transplant patients: an initial experience at a single center.

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effects.

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

Conversion to everolimus in maintenance liver transplant patients: a multicenter, retrospective analysis

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

Timing of Conversion to Mammalian Target of Rapamycin Inhibitors Is Crucial in Liver Transplant Recipients With Impaired Renal Function at Transplantation

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

Hepatocellular carcinoma and liver transplantation: a 12-year experience

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

Risk factors of survival after liver transplantation for HCC: a multivariate single-center analysis

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

Impact of tumor size, number of tumors and neutrophil-to-lymphocyte ratio in liver transplantation for recurrent hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

Significance of tumor necrosis for outcome of patients with hepatocellular carcinoma receiving locoregional therapy prior to liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

Living donor liver transplantation for hepatocellular carcinoma: Increased recurrence but improved survival.

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

Factors that affect deceased donor liver transplantation rates in the United States in addition to the Model for End-stage Liver Disease score

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

Hepatocellular carcinoma recurrence among liver transplant recipients within the Milan criteria

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

Liver transplantation for hepatocellular carcinoma: long-term results suggest excellent outcomes

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

Sirolimus in liver transplant recipients: a large single-center experience.

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

Sirolimus-based immunosuppression therapy in liver transplantation for patients with hepatocellular carcinoma exceeding the Milan criteria

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

Impact of sirolimus on the recurrence of hepatocellular carcinoma after liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

Long-term experience with liver transplantation for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

Results of a phase 4 trial of Tacrobell® in liver transplantation patients: a multicenter study in South Korea

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

Retracted: A Scoring Model Based on Neutrophil to Lymphocyte Ratio Predicts Recurrence of HBV-Associated Hepatocellular Carcinoma after Liver Transplantation

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

The influence of OKT3 therapy on hepatocellular carcinoma recurrence following liver transplantation.

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

m-TOR inhibitors: what role in liver transplantation?

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

Recurrence of Hepatocellular Carcinoma After Liver Transplantation

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12372

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38221424&oldid=1879135628"